SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-055663
Filing Date
2017-11-02
Accepted
2017-11-02 08:38:14
Documents
63
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv477368_10q.htm 10-Q 531423
2 EXHIBIT 31.1 tv477368_ex31-1.htm EX-31.1 11521
3 EXHIBIT 31.2 tv477368_ex31-2.htm EX-31.2 11560
4 EXHIBIT 32.1 tv477368_ex32-1.htm EX-32.1 6111
  Complete submission text file 0001144204-17-055663.txt   4228179

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20170930.xml EX-101.INS 904003
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20170930.xsd EX-101.SCH 39100
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20170930_cal.xml EX-101.CAL 46299
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20170930_def.xml EX-101.DEF 289584
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20170930_lab.xml EX-101.LAB 309527
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20170930_pre.xml EX-101.PRE 318077
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 171170881
SIC: 2834 Pharmaceutical Preparations